Healthcare Sector

AZN

Market Tracker

$94.70
+0.71
(+0.75%)
5:20 am
Next Earnings: (est.) n/a
  • AZN (Selected)

    AstraZeneca PLC

AZN Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

AZN Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

AZN Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

AZN Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

AZN Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

AZN Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
06/17/2027 CALL $87.50 152 +134 +744.44%
04/17/2026 CALL $95.00 1,494 +109 +7.87%
01/16/2026 CALL $92.50 2,738 +45 +1.67%
02/20/2026 CALL $97.50 294 +28 +10.53%
06/18/2026 PUT $87.50 193 +27 +16.27%
04/17/2026 PUT $90.00 1,037 +25 +2.47%
01/16/2026 PUT $95.00 1,467 -40 -2.65%
01/16/2026 CALL $82.50 1,835 -42 -2.24%
01/16/2026 CALL $95.00 3,241 -59 -1.79%
04/17/2026 CALL $80.00 1,401 -65 -4.43%
01/16/2026 CALL $80.00 6,542 -87 -1.31%
01/16/2026 PUT $97.50 0 -177 -100.00%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

AZN Major Holders

Name Pct Held Shares Total
Washington Mutual Investors Fund 1.04% 27.18M 1.81B
Vanguard/Primecap Fund 0.99% 25.87M 1.72B
Vanguard/Wellington Fund Inc. 0.73% 19.18M 1.28B
American Mutual Fund Inc 0.33% 8.7M 578.3M
Price (T.Rowe) Health Sciences Fund 0.30% 8M 531.71M
Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF 0.30% 7.93M 526.89M
Vanguard Fenway Funds-Equity Income Fund 0.27% 7.11M 472.77M
Price (T.Rowe) Value Fund 0.22% 5.86M 389.5M
Vanguard Fenway Fds-Primecap Core Fund 0.21% 5.63M 374.17M
Vanguard/Wellesley Income Fund 0.20% 5.28M 351.09M

AZN News

  • The Newest Stock in the Nasdaq-100 Soared 549,000% Since Its IPO, and It's Still a Buy Right Now, According to Wall Street (Hint: Not Strictly a Tech Company)

    01/15 04:02 am

    The Motley Fool

    Read more
  • Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference

    01/14 09:25 pm

    GlobeNewswire Inc.

    Read more
  • Generalized Myasthenia Gravis Market Outlook Shows Strong Momentum During the Forecast Period (2025–2034) Driven by Novel Immunotherapies | DelveInsight

    01/14 02:00 pm

    GlobeNewswire Inc.

    Read more
  • HUTCHMED Highlights Publication of Phase III SACHI Results in The Lancet

    01/14 12:00 am

    GlobeNewswire Inc.

    Read more
  • 1 Quantum Computing Stock to Buy that Could Soar in 2026

    01/13 03:16 pm

    The Motley Fool

    Read more
  • Systemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics – Approvals of BENLYSTA and SAPHNELO, Plus a Strong Pipeline | DelveInsight

    01/13 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Pharmacy XD Launches Nationally Licensed Direct-to-Patient Mail Order Pharmacy and Distribution Platform - Headquartered in Florida's Fastest-Growing Healthcare Corridor

    01/08 05:30 pm

    Benzinga

    Read more
  • AstraZeneca's Self-Injectable Lupus Drug Shines In Late-Stage Trial

    01/06 07:43 am

    Benzinga

    Read more
  • G-Protein Coupled Receptors (GPCRs) Market Size to Hit USD 6.04 Billion by 2032, Growing at a CAGR of 5.59% - SNS Insider

    01/05 11:00 am

    GlobeNewswire Inc.

    Read more
  • Invest Outside the U.S. With These Top International ETFs

    12/31 03:20 pm

    The Motley Fool

    Read more
  • AstraZeneca's Lung Cancer Combo Falls Short In Phase 3 Trial

    12/22 01:19 pm

    Benzinga

    Read more
  • GSK Expands Use Of Urinary Tract Infection Drug For Gonorrhoea Patients

    12/12 12:12 pm

    Benzinga

    Read more
  • Gestational Diabetes Market to Reach USD 22.58 Billion by 2034, Driven by Rising Awareness and Rapid Innovations

    12/11 11:00 am

    GlobeNewswire Inc.

    Read more
  • Drugmakers Briefed As Vaccine Skeptics Like RFK Jr. Probe RSV Therapy Risks

    12/09 12:30 pm

    Benzinga

    Read more
  • AstraZeneca, GSK Among Executives Asked To Help Redesign UK Pricing Rules-Report

    12/03 01:24 pm

    Benzinga

    Read more
  • AstraZeneca's Hard To Control Hypertension Drug Advances, With FDA Decision Expected In 2026

    12/03 11:27 am

    Benzinga

    Read more
  • Seasonal Vaccines Market Accelerating Growth and Rising Opportunities Through 2035

    12/03 11:00 am

    GlobeNewswire Inc.

    Read more
  • Vaccine Development Company Landscape Report 2025: Recent Expansions, Partnerships and Collaborations, Big Pharma Initiatives and Cost Price Analysis

    12/02 05:37 am

    GlobeNewswire Inc.

    Read more
  • Geriatric Care Services Market is expected to generate a revenue of USD 2.03 Billion by 2032, Globally, at 7.98% CAGR: Verified Market Research®

    11/27 11:50 pm

    GlobeNewswire Inc.

    Read more
  • HER2-positive Gastric Cancer Clinical Trial Pipeline: Insights into a Growing Landscape with 20+ Companies Advancing Novel Treatments| DelveInsight

    11/27 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Antitumor ADC Drugs Market Forecast Shows Strong 12.86% CAGR Through 2035

    11/27 10:00 am

    GlobeNewswire Inc.

    Read more
  • HUTCHMED Highlights Clinical Data to be Presented at the 2025 ESMO Asia Congress and the 2025 ASH Annual Meeting

    11/26 08:00 pm

    GlobeNewswire Inc.

    Read more
  • Chronic Heart Failure Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight

    11/25 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Q3 2025 Contract Research Organization (CRO) Activity and Intel Report Featuring ICON, Astrazeneca, Akesobio, CSPPC Pharmaceutical, ImmunityBio, and Boryung

    11/25 10:00 am

    GlobeNewswire Inc.

    Read more
  • AstraZeneca Doubles Down On US Biologics Buildout As Drug Discovery Partnership Grows

    11/24 01:58 pm

    Benzinga

    Read more
  • Why AstraZeneca Stock Bumped Higher Today

    11/21 07:23 pm

    The Motley Fool

    Read more
  • Burning Rock Reports Third Quarter 2025 Financial Results

    11/20 02:52 am

    GlobeNewswire Inc.

    Read more
  • Unnatural Amino Acids Market to Reach US$ 5.03 Billion By 2032 Driven by Advances in Drug Discovery, Biologics and Protein Engineering - SNS Insider

    11/11 04:38 am

    GlobeNewswire Inc.

    Read more
  • Why AstraZeneca Stock Was a Winner Today

    11/10 06:20 pm

    The Motley Fool

    Read more
  • Medera Presents Late-Breaking Data from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at American Heart Association Scientific Sessions 2025

    11/09 10:00 am

    GlobeNewswire Inc.

    Read more
  • Eli Lilly, Novo Nordisk Make Weight-Loss Drugs More Affordable Via Medicare, Medicaid, TrumpRx

    11/06 03:10 pm

    Benzinga

    Read more
  • Up 47%, Should You Buy IonQ Right Now?

    10/30 10:20 am

    The Motley Fool

    Read more
  • Step Pharma announces the appointment of Dr Karen Smith as Chief Medical Officer

    10/28 08:00 am

    GlobeNewswire Inc.

    Read more
  • Eccogene Eyes Hong Kong IPO With Experimental Weight-Loss Drug, AstraZeneca Partnership

    10/23 09:22 am

    Benzinga

    Read more
  • Small Cell Lung Cancer Market Research 2025-2035: Growth Driven by Advancements in Novel Therapies, Including Immunotherapies, Targeted Therapies, and Combination Treatments

    10/21 04:41 am

    GlobeNewswire Inc.

    Read more
  • Prediction: This Unstoppable Vanguard ETF Will Beat the S&P 500 Again in 2026

    10/20 04:48 am

    The Motley Fool

    Read more
  • Merck's Keytruda Plus Chemo Regimen Shows Overall Survival Benefit In Recurrent Ovarian Cancer Patients

    10/16 10:33 am

    Benzinga

    Read more
  • Eli Lilly's Oral Weight Loss Drug Shows Superiority Over Two Approved Drugs

    10/15 01:24 pm

    Benzinga

    Read more
  • AstraZeneca Expands Virginia Investment To $4.5 Billion For Cancer, Obesity Drugs

    10/09 03:22 pm

    Benzinga

    Read more
  • AstraZeneca's Baxdrostat Shows Meaningful Blood Pressure Control In Patients With Resistant Hypertension

    10/07 11:40 am

    Benzinga

    Read more
  • Theolytics Appoints Experienced Medical Oncologist Matilde Saggese, MD, as Chief Medical Officer

    10/07 03:00 am

    GlobeNewswire Inc.

    Read more
  • AstraZeneca/Daiichi Sankyo Partnered Breast Cancer Drug Shows Survival Benefit Over Chemotherapy

    10/06 08:50 am

    Benzinga

    Read more
  • AstraZeneca Stock Is Up 10% on Tariff News. But Is the Pharmaceutical Giant a Buy?

    10/02 12:22 pm

    The Motley Fool

    Read more
  • AstraZeneca Moves From ADRs To NYSE Listing

    09/29 08:25 am

    Benzinga

    Read more
  • Your AstraZeneca Medicine Could Be Cheaper As Much As 70%

    09/26 01:34 pm

    Benzinga

    Read more
  • Trump’s Tariff Gambit: Pharma in the Crosshairs and Global Markets on Edge

    09/26 02:54 am

    Investing.com

    Read more
  • Advanced Liver Cancer Clinical Trial Pipeline Shows Potential with Active Contributions from 50+ Key Companies | DelveInsight

    09/25 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Influenza Vaccine Market Size to Cross USD 16.73 billion by 2034 at 7.02% CAGR

    09/25 11:00 am

    GlobeNewswire Inc.

    Read more
  • United Kingdom The Worst European Country For Drug Prices: Eli Lilly CEO

    09/24 02:15 pm

    Benzinga

    Read more
  • Burning Rock's OncoGuide™ OncoScreen™ Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer

    09/24 02:42 am

    GlobeNewswire Inc.

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: